Skip to main content

Day: November 19, 2024

Fusion Fuel Green Agrees to Acquire Majority Stake in Quality Industrial Corp. Expanding into Gas and Engineering Services

Acquisition of Profitable, Cash Flow-Generating Business Broadens Service Offerings Across Energy Value Chain DUBLIN, Ireland, Nov. 19, 2024 (GLOBE NEWSWIRE) — Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel” or the “Company”), a leading green hydrogen technology and engineering company, today announced it has signed a binding agreement to acquire an approximately 70% ownership interest in Quality Industrial Corp., a Nevada corporation (“QIND”) (OTC PINK: QIND) from its controlling shareholders (“the QIND sellers”). QIND operates in the gas supply and services sector, with expertise across the industrial and utility value chain. This acquisition, which the Company expects to close shortly, marks a pivotal step in Fusion Fuel’s strategy to build a full-service energy engineering business, combining capabilities in both...

Continue reading

EuroDry Ltd. Reports Results for the Nine-Month Period and Quarter Ended September 30, 2024

ATHENS, Greece, Nov. 19, 2024 (GLOBE NEWSWIRE) — EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and provider of seaborne transportation for drybulk cargoes, announced today its results for the three and nine-month periods ended September 30, 2024. Third Quarter 2024 Highlights:Total net revenues for the quarter of $14.7 million.Net loss attributable to controlling shareholders, of $4.2 million or $1.53 loss per share basic and diluted, respectively.Adjusted net loss1 attributable to controlling shareholders for the quarter of $3.9 million or $1.42 loss per share basic and diluted, respectively.Adjusted EBITDA1 for the quarter was $0.5 million.An average of 13.0 vessels were owned and operated during the third quarter of 2024 earning an average time charter equivalent...

Continue reading

TowerBrook and CD&R Complete Acquisition of R1 RCM

R1 RCM Becomes Privately Held Company; Joe Flanagan Reappointed as CEO MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) — R1 RCM Inc. (“R1”), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with TowerBrook Capital Partners (“TowerBrook”) and Clayton, Dubilier & Rice (“CD&R”) have completed their previously announced acquisition of R1. On August 1, 2024, TowerBrook, CD&R and R1 announced that they had entered into a definitive merger agreement under which all outstanding shares of R1 common stock that TowerBrook did not own would be acquired for $14.30 per share in cash, valuing R1 at approximately $8.9 billion. With the completion of the transaction, R1’s common stock has ceased trading and will no longer be listed on Nasdaq. R1 also intends to make...

Continue reading

Blue Mantis Acquires Colligio; Launches Collaboration/Unified Communications Practice

Acquisition Significantly Bolsters Blue Mantis’s Expertise and Capabilities in Delivering Best-in-Class UC Solutions to its Client Base PORTSMOUTH, N.H., Nov. 19, 2024 (GLOBE NEWSWIRE) — Blue Mantis, a leading provider of digital strategy and services specializing in managed services, cybersecurity, and cloud solutions, today announced that it has acquired Colligio, a provider of unified communications, networking and security solutions, specializing in Cisco-based technologies, headquartered in Walpole, MA with customers and employees located throughout the Northeast.  With the acquisition, Blue Mantis is launching a new Collaboration/Unified Communications Practice, allowing it to take a more focused approach to delivering best-in-class collaboration and communication solutions, backed by world-class managed services. Colligio...

Continue reading

Star Equity Holdings, Inc. Announces 2024 Third Quarter Financial Results

Recent large commercial contract wins validate optimism for Building Solutions upturn Enservco investment diversifies portfolio; marks entry into Energy Services and Transportation & Logistics OLD GREENWICH, Conn., Nov. 19, 2024 (GLOBE NEWSWIRE) — Star Equity Holdings, Inc. (Nasdaq: STRR; STRRP) (“Star” or the “Company”), a diversified holding company, reported today its financial results for the third quarter (Q3) ended September 30, 2024. All 2024 and 2023 amounts in this release are unaudited. Following the sale of our Digirad Health business on May 4, 2023, all financial results for the 2023 reporting period, unless stated otherwise, relate to continuing operations, which currently include two divisions: Building Solutions (formerly known as Construction) and Investments. Q3 2024 Financial Highlights vs. Q3 2023 (unaudited)Revenues...

Continue reading

Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

BEDMINSTER, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to present at three upcoming investor conferences: Evercore 7th Annual HealthCONx ConferenceTuesday, December 3, 2024 at 10:50 a.m. ET in Miami, FL Citi 2024 Global Healthcare ConferenceWednesday, December 4, 2024 at 3:15 p.m. ET in Miami, FL Piper Sandler 36th Annual Healthcare ConferenceThursday, December 5, 2024 at 11:30 a.m. ET in New York, NY A live and achieved webcast of the presentations can be accessed under “Events & Presentations” in the Investors section of the Company’s...

Continue reading

Digitalist Group Plc Oy – Managers’ Transactions

Digitalist Group Plc Oy – Managers’ Transactions Person subject to the notification requirement  Name: Wilhelm Rosenlew  Position: Member of the Board/Deputy member Issuer: Digitalist Group Plc Oy  LEI: 743700AL68PUX6JMS644 Notification type: INITIAL NOTIFICATION  Reference number: 84921/5/4 Transaction date: 2024-11-12  Venue: NASDAQ HELSINKI LTD (XHEL)  Instrument type: SHARE  ISIN: FI0009008007 6 / 7Nature of transaction: DISPOSAL Transaction details  (1): Volume: 440000 Unit price: 0.0182 EUR  (2): Volume: 40000 Unit price: 0.0186 EUR  (3): Volume: 40000 Unit price: 0.0182 EUR Aggregated transactions  (3): Volume: 520000 Volume weighted average price: 0.01823 EURAdditional information: Digitalist Group Plc CEO Magnus Leijonborg, tel. +46 76 315 8422, magnus.leijonborg@digitalistgroup.com Chairman of the Board...

Continue reading

Hepsiburada to Announce Third Quarter 2024 Results on December 10, 2024

ISTANBUL, Nov. 19, 2024 (GLOBE NEWSWIRE) — D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS), a leading Turkish e-commerce platform, will report its unaudited financial results for the third quarter ending September 30, 2024 before the U.S. market opens on Tuesday, December 10, 2024. Conference Call and Webcast DetailsHepsiburada’s management will host an analyst and investor conference call and live webcast to discuss its financial results at 16.00 İstanbul / 13.00 London / 8.00 a.m. New York time on Tuesday, December 10, 2024. Live webcast can be accessed via https://87399.themediaframe.eu/links/hepsiburada241210.html. A replay will be available on the Hepsiburada Investor Relations website https://investors.hepsiburada.com following the call. Hepsiburada’s results presentation will be available...

Continue reading

EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis

          Treatment with robotic HIFU showed reduction in moderate and severe post-operative complications and reduced hospital stay compared to surgeryLYON, France, November 19, 2024 – EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, today announced a moderated scientific presentation of clinical data comparing Focal One HIFU versus surgery for the treatment of deep infiltrating endometriosis at the 2024 AAGL Global Congress, which took place from November 16-19, 2024, in New Orleans, LA. The presentation was entitled, “Evaluation of rectal endometriosis treatment with high-intensity focused ultrasound versus surgery: a retrospective multicenter study”, and was delivered by Professor Gil Dubernard, Head of Gynecology Department at Croix-Rousse University Hospital, Lyon, France, and...

Continue reading

Novartis ranks first in 2024 Access to Medicine Index

The Index spotlights Novartis leadership in research and development, and governance of access, with Novartis ranking first in these sub-topicsNovartis malaria access plans, widespread registration of products in LMICs, and inclusive business model to improve access to products in multiple countries were all highlighted as Best Practice across the industryNovartis has risen three places to secure the top spot on the 2024 Access to Medicine IndexBasel, November 19, 2024 – Novartis has ranked first in the 2024 Access to Medicine Index (ATMI) report published today, highlighting the company’s leadership in improving access to medicines around the world. The Index, published every two years, is an independent report that assesses 20 of the world’s largest research-based pharmaceutical companies on their efforts to improve access to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.